ArticleAging2023

Efficacy and safety analysis of a HER2-targeting antibody-drug conjugate combined with immune checkpoint inhibitors in solid tumors: a real-world study.

Yi-Xin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.